INmune Bio Inc. Common stock (INMB)
Price trend is one of its highest-scoring factors; short-term momentum score is on the low side; score for how it compares with the broader market is below the middle.
INMB scores higher than 67% of the 1,101 tickers we compare it with (Health Care).
As of 9 October 2026, INmune Bio Inc. Common stock (INMB) scores 50 out of 100 on the Market Census six-factor composite, which puts it at the Average score level. The score is made from six named factors: price trend, strength vs the market, company finances, insider trades, market mood and recent momentum. It records what they read on 9 October 2026, and it is not investment advice.
Updated · scores usually change about once a day
Key statistics
Market fields as reported. An em-dash means we hold no value for this ticker — most of the universe has no daily price or volume read.
- Relative volume
- 0.29× 30-day average
- 52-week range
- 1.09 – 2.60
- Market cap
- $64.67M
- Earnings date
- 4 Nov 2026
- Volume
- 91,630
- Avg. volume (30d)
- 315,034
- Open
- 1.84
- Previous close
- 1.83
- Day's range (regular session)
- 1.84 – 1.91
The last trade can be an extended-hours trade, so it can sit outside the regular-session range.
Shown without a peer ranking — we hold no percentile for these yet, so there is nothing here to locate them against.
- Beta
- —
- P/E (TTM)
- —
- EPS (TTM)
- —
Score breakdown · six named factors
Each bar is one part of the score, from 0 to 100. Read what the score means.
What the score says about INMB right now
INmune Bio Inc. Common stock (INMB) currently scores 50/100 on the Market Census six-factor composite, at the Average score level. INMB is +3.28% on the day and -2.07% over five sessions as of the most recent tick. Average sits in the middle. The good and the bad in INMB's data roughly balance out right now. INMB's strongest factor is price trend at 89/100 — a very strong read on which way the price has been going. The weakest factor is Momentum at 17/100 — well below average recent price moves. Low momentum + high trend often marks a base-building phase rather than a topping pattern.
Generated from the six-factor breakdown above. Changes when the underlying scores do, usually about once a day. More on what the score means.
See INMB in the scanner
This page is free to read with no account at all. Signing up takes an email and a password: a free account runs the scanner on the top 10 scored rows of any scan, keeps one saved screen, a 5-ticker watchlist, and opens 12 ticker detail pages a day. The card is what starts a 30-day Premium trial — $0 that day, then $19.99/month from day 30, cancel online any time before then — and that is what turns on every matching row instead of the first 10, alerts, the 200-ticker watchlist and recent insider buys (SEC Form 4).
Recent INMB news
Latest headlines that name INmune Bio, one per story, sourced from Market Census’s news feed (Polygon/Massive + Finnhub).
- INmune Bio Appoints Sanofi Rare-Disease Executive and Biopharma Business Development Leader to BoardYahoo
- INmune Bio to Present at the H.C. Wainwright Global Investment ConferenceYahoo
- INmune Bio Inc. (INMB) Q2 2026 Earnings Call TranscriptSeekingAlpha
- INmune Bio (NASDAQ:INMB) Beats Q2 Loss Estimates but Shares Tumble on Business UpdateChartMill
- INmune Bio Inc. to Report Second Quarter 2026 Financial Results and Provide Corporate Update on Thursday, August 6thYahoo
Saved snapshot; the news and prices on this page can be an hour old or more.
Similar setups in Health Care right now
Six health care tickers whose composite scores are closest to INMB’s 50, all within 1 point.
Sorted by closeness to INMB’s composite score within Health Care. Saved snapshot; can be an hour old or more. Run the full scanner →
Prices delayed about 15 minutes; scores usually change about once a day. Not investment advice — see risk disclosure.